Table 1. Genotype and allele distributions for NR3B insCGTT type between patients with schizophrenia and controls.
Marker | SCZ (n = 586) | CON (n = 754) | Genotypic | SCZ | CON | Allelic | OR | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP IDs | Chr Position a | M/m b | gene | M/M | M/m | m/m | M/M | M/m | m/m | p value | MAF | p value | (95% CI) | |
rs10666583 | 1004896:1004897 | - / CGTT | Exon3 | 0.84 | 0.15 | 0.0068 | 0.88 | 0.11 | 0.0080 | 0.045 | 0.084 | 0.062 | 0.035 | 1.37(1.02–1.84) |
SCZ, patients with schizophrenia; CON, healthy controls; M, major allele; m, minor allele; MAF, minor allele frequency; OR, odds ratio.
adb SNP build 129.
bThe first alleles shown are major alleles. The allele is represented according to the plus strand DNA sequence.
Significant p values are shown as bold-faced and underlined type.